These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 34860699)

  • 1. What constitutes the most cautious approach for a pregnant person with weak D type 4.0?
    Flegel WA; Bodnar M; Clarke G; Hannon J; Lieberman L
    CMAJ; 2021 Jun; 193(24):E916. PubMed ID: 34860699
    [No Abstract]   [Full Text] [Related]  

  • 2. RHD alleles among pregnant women with serologic discrepant weak D phenotypes from a multiethnic population and risk of alloimmunization.
    Bub CB; Aravechia MG; Costa TH; Kutner JM; Castilho L
    J Clin Lab Anal; 2018 Jan; 32(1):. PubMed ID: 28374955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relevance and costs of RHD genotyping in women with a weak D phenotype.
    Laget L; Izard C; Durieux-Roussel E; Gouvitsos J; Dettori I; Chiaroni J; Ferrera-Tourenc V
    Transfus Clin Biol; 2019 Feb; 26(1):27-31. PubMed ID: 29866395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serological weak D phenotypes: a review and guidance for interpreting the RhD blood type using the RHD genotype.
    Sandler SG; Chen LN; Flegel WA
    Br J Haematol; 2017 Oct; 179(1):10-19. PubMed ID: 28508413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transfusion support during childbirth for a woman with anti-U and the
    Yin Q; Srivastava K; Brust DG; Flegel WA
    Immunohematology; 2021 Mar; 37(1):1-4. PubMed ID: 33962485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Standardization of a multiplex assay to identify weak D types in a mixed-race Brazilian population.
    Silva TCS; Dezan MR; Cruz BR; Costa SSM; Dinardo CL; Bordin JO
    Immunohematology; 2023 Sep; 39(3):93-100. PubMed ID: 37843969
    [No Abstract]   [Full Text] [Related]  

  • 7. Resolving variable maternal D typing using serology and genotyping in selected prenatal patients.
    Clarke G; Hannon J; Berardi P; Barr G; Cote J; Fallis R; Alport T; Lane D; Petraszko T; Ochoa G; Goldman M
    Transfusion; 2016 Dec; 56(12):2980-2985. PubMed ID: 27611891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genotype analysis to clarify RhD variants in discrepant samples of Chilean population.
    Aburto A; Zapata D; Retamales E; Fernández J; Barra G; Peña F; Cárcamo S; Saavedra N; Sandoval C; Orellana J; Caamaño J
    Front Immunol; 2023; 14():1299639. PubMed ID: 38116010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunoserology and RHD Genotype Analysis of DVI Type 3 Genotype Pregnant Women with Anti-D].
    Liang QN; Liao ZJ; Zhang RQ; Ji YL; Luo GP; Li MN
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Dec; 25(6):1810-1814. PubMed ID: 29262921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin D binding protein rs7041 genotype alters vitamin D metabolism in pregnant women.
    Ganz AB; Park H; Malysheva OV; Caudill MA
    FASEB J; 2018 Apr; 32(4):2012-2020. PubMed ID: 29196501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RHD sequencing: a new tool for decision making on transfusion therapy and provision of Rh prophylaxis.
    Legler TJ; Maas JH; Köhler M; Wagner T; Daniels GL; Perco P; Panzer S
    Transfus Med; 2001 Oct; 11(5):383-8. PubMed ID: 11696232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence, genotype distribution and mutations of hepatitis B virus and the associated risk factors among pregnant women residing in the northern shores of Persian Gulf, Iran.
    Taherkhani R; Farshadpour F
    PLoS One; 2022; 17(3):e0265063. PubMed ID: 35271684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Financial implications of RHD genotyping of pregnant women with a serologic weak D phenotype.
    Kacker S; Vassallo R; Keller MA; Westhoff CM; Frick KD; Sandler SG; Tobian AA
    Transfusion; 2015 Sep; 55(9):2095-103. PubMed ID: 25808011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multi-centre study on the performance of the molecular genotyping platform ID RHD XT for resolving serological weak RhD phenotype in routine clinical practice.
    Londero D; Monge J; Hellberg A
    Vox Sang; 2020 Apr; 115(3):241-248. PubMed ID: 31912520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transfusion support for a woman with
    Srivastava K; Bueno MU; Flegel WA
    Immunohematology; 2022 Apr; 38(1):17-24. PubMed ID: 35852060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No. 367-2019 Canadian Guideline for Physical Activity throughout Pregnancy.
    Mottola MF; Davenport MH; Ruchat SM; Davies GA; Poitras V; Gray C; Jaramillo Garcia A; Barrowman N; Adamo KB; Duggan M; Barakat R; Chilibeck P; Fleming K; Forte M; Korolnek J; Nagpal T; Slater L; Stirling D; Zehr L
    J Obstet Gynaecol Can; 2018 Nov; 40(11):1528-1537. PubMed ID: 30297272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulation of multiple hepatitis B virus genotypes in individual pregnant women seeking antenatal care in northern Ghana.
    Anabire NG; Quaye O; Helegbe GK
    Virol J; 2023 Jul; 20(1):149. PubMed ID: 37443015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying obstetrics patients in whom RHD genotyping can be used to assess risk of D alloimmunization.
    Horn TN; Keller J; Keller MA; Klinger L
    Immunohematology; 2020 Dec; 36(4):146-151. PubMed ID: 33544620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guide to Rho(D) Immune Globulin in Women With Molecularly Defined Asian-type DEL (c.1227G>A).
    Jeong IH; Yu S; Kim TY; Oh SY; Cho D
    Ann Lab Med; 2024 Jul; 44(4):307-313. PubMed ID: 38384203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Guide to Terminology for Rh Immunoprophylaxis.
    Sandler SG; Queenan JT
    Obstet Gynecol; 2017 Sep; 130(3):633-635. PubMed ID: 28796682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.